Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of HDM1005 in adults with type 2 diabetes mellitus inadequately controlled after diet and exercise or metformin
CTR20250658Phase 2Completed
- Sponsor
- 杭州中美华东制药有限公司 (Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.)
- Start
- Apr 2025
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of poterepatide in type 2 diabetes mellitus (T2DM), sponsored by 杭州中美华东制药有限公司 (Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.). Started Apr 2025; status: completed.
02
Drugs
poterepatide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on CTR20250658.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20250658.